AMANDA HOOVER: Open Payments
NPI 1992322697 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$165 in 4 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $271 · 2025 $165
Food & beverage: $165
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $114 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Avita Medical Americas, LLC | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
Products named: INGREZZA, AUSTEDO XR, Permeaderm, VRAYLAR.
Industry payments across PA — which companies pay providers there.
